Endocrinology and Metabolism Unit, Faculty of Medicine, Prince of Songkla University, Hatyai, Thailand.
Clinical Nutrition and Obesity Medicine Unit, Faculty of Medicine, Prince of Songkla University, Hatyai, Thailand.
Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231221202. doi: 10.1177/14791641231221202.
To investigate temporal changes in glycaemic control and weight contributing to insulin resistance (IR), in Thai individuals with type 1 diabetes (T1D)
Longitudinal data of 69 individuals with T1D were retrospectively collected over a median follow-up of 7.2 years. The estimated glucose disposal rate (eGDR), a marker of IR, was calculated using an established formula. Individuals were assigned as insulin-sensitive T1D (the latest eGDR≥8 mg/kg/min), or insulin-resistant T1D/double diabetes (the latest eGDR<8 mg/kg/min). Generalised linear mixed model was employed to compare the temporal patterns of HbA1c, BMI, and eGDR between the two groups.
26 insulin-resistant T1D had a gradual decline in eGDR, corresponding with increased weight and HbA1c. In contrast, 43 insulin-sensitive T1D had stable insulin sensitivity with an improvement in HbA1c over time, associated with a modest weight gain. Fluctuations of glucose levels were observed during the early diabetes course leading to unstable eGDR, thus limiting the use of eGDR to classify insulin-resistant T1D.
T1D individuals who eventually develop IR are likely to experience early increasing IR over time. In contrast, those who ultimately do not have IR, maintain their insulin sensitivity throughout their course at least in the medium term.
研究泰国 1 型糖尿病(T1D)患者血糖控制和体重随时间的变化对胰岛素抵抗(IR)的影响。
回顾性收集了 69 名 T1D 患者的纵向数据,中位随访时间为 7.2 年。采用已建立的公式计算胰岛素抵抗的标志物——估计葡萄糖处置率(eGDR)。将患者分为胰岛素敏感 T1D(最新 eGDR≥8mg/kg/min)或胰岛素抵抗 T1D/双重糖尿病(最新 eGDR<8mg/kg/min)。采用广义线性混合模型比较两组之间 HbA1c、BMI 和 eGDR 的时间变化模式。
26 例胰岛素抵抗 T1D 的 eGDR 逐渐下降,体重和 HbA1c 增加。相比之下,43 例胰岛素敏感 T1D 的胰岛素敏感性稳定,HbA1c 随时间改善,体重略有增加。在糖尿病早期,血糖波动导致 eGDR 不稳定,从而限制了 eGDR 用于分类胰岛素抵抗 T1D。
最终发生 IR 的 T1D 患者可能会随着时间的推移经历早期逐渐增加的 IR。相比之下,那些最终没有 IR 的患者,至少在中期,在整个病程中保持胰岛素敏感性。